American Association for Cancer Research

AACR Annual Meeting 2014: Clinical Research and Clinical Trials

AACR Annual Meeting 2014

The AACR Annual Meeting covers the cancer research spectrum from the bench to the clinic. As such, we are extremely pleased to be featuring a clinical trial of a novel drug that is showing great promise for breast cancer patients in our opening plenary session, Harnessing Breakthroughs, Targeting Cures.

  • Final results of a randomized Phase II study of PD 0332991, a cyclin-dependent kinase (CDK)-4/6 inhibitor, in combination with letrozole vs letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (PALOMA-1; TRIO-18)

AACR has a long-standing commitment to highlighting the best science-based clinical research and will continue this tradition by once again offering four Clinical Trials Symposia featuring four clinical trials each, with an in-depth discussion of the science behind the trial following each presentation.

Additionally, many interesting clinical studies will be presented in Clinical Trials Minisymposia:

Further, there are opportunities to see even more clinical studies in Clinical Trials Poster Sessions in Hall A-E of the San Diego Convention Center.




Click here to access the AACR Annual Meeting 2014 program online or to download the Annual Meeting App.

 


AACR Annual Meeting 2014 • April 5-9, 2014 • San Diego Convention Center • San Diego, California